TY - CHAP M1 - Book, Section TI - Fluid and Electrolyte Disturbances Further Readings A1 - Mount, David B. A2 - Jameson, J. Larry A2 - Fauci, Anthony S. A2 - Kasper, Dennis L. A2 - Hauser, Stephen L. A2 - Longo, Dan L. A2 - Loscalzo, Joseph PY - 2018 T2 - Harrison's Principles of Internal Medicine, 20e AB - ChoiM et al: K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768, 2011.[PubMed: ]MountDB, Zandi-NejadK: Disorders of potassium balance, in Brenner and Rector’s The Kidney, 10th ed, K Skorecki et al (eds). Philadelphia, W.B. Saunders & Company, 2016, pp 559600.PackhamDK et al: Sodium zirconium cyclosilicate in hyperkalemia. N Engl J Med 372:222, 2015.[PubMed: ]PerianayagamA et al: DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 3:331, 2008.[PubMed: ]SchrierRW: Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18:2028, 2007.[PubMed: ]SoodL et al: Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis 61:571, 2013.[PubMed: ]SoupartA et al: Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol 7:742, 2012.[PubMed: ]WeirMR et al: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. N Engl J Med 372:211, 2015.[PubMed: ] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesspharmacy.mhmedical.com/content.aspx?aid=1178487227 ER -